Open Access · CC BY-NC-ND 4.0
Methimazole-Induced Severe Agranulocytosis Treated With High-Dose G-CSF
AACE Endocrinology and Diabetes · 2026-09
DOI: 10.1016/j.aed.2026.08.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift AACE Endocrinology and Diabetes, 2026-09. Verfasst von Shivesh Shah und 3 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shah, S., Mathur, D., Shah, S., & Bao, G. (2026). Methimazole-Induced Severe Agranulocytosis Treated With High-Dose G-CSF. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.08.015
Vancouver
Shah S, Mathur D, Shah S, Bao G. Methimazole-Induced Severe Agranulocytosis Treated With High-Dose G-CSF. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.08.015
BibTeX
@article{Shah2026,
author = {Shah, Shivesh and Mathur, Diya and Shah, Soham and Bao, Ginny},
title = {Methimazole-Induced Severe Agranulocytosis Treated With High-Dose G-CSF},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
doi = {10.1016/j.aed.2026.08.015}
}
EUVIMED